Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Azelis Group NV | AZE | Apr 16, 2025 | 15.39 | -0.97 |
Banco Bilbao Vizcaya Argentaria SA | BBV | Apr 16, 2025 | 7.80 | 0.00 |
Banco Santander SA | SANTA | Apr 16, 2025 | 3.58 | 0.00 |
Banimmo SA | BANI | Apr 16, 2025 | 2.93 | +0.83 |
Banque Nationale de Belgique | BNB | Apr 16, 2025 | 320.00 | -3.03 |
Barco NV | BAR | Apr 16, 2025 | 11.18 | -7.60 |
Basilix | BAS | Apr 16, 2025 | 27.80 | 0.00 |
Beaulieu Av Certificates | BEAB | Apr 16, 2025 | 1.19 | 0.00 |
Befimmo SA | BEFB | Apr 16, 2025 | 46.10 | 0.00 |
Bel20 | BEL20 | Apr 16, 2025 | 4 200.98 | +0.14 |
Belreca - Belgian Resources and Capital Company | BELR | Apr 16, 2025 | 7.50 | 0.00 |
Beluga NV | BELU | Apr 16, 2025 | 0.32 | 0.00 |
Belysse Group N.V. | BELYS | Apr 16, 2025 | 0.77 | -4.94 |
Biocartis Group NV | BCART | Apr 16, 2025 | 0.29 | 0.00 |
Biosenic | BIOS | Apr 16, 2025 | 0.00 | -10.00 |
Biotalys | BTLS | Apr 16, 2025 | 3.12 | -2.50 |
Boeing | BOEI | Apr 16, 2025 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | Apr 16, 2025 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | Apr 16, 2025 | 1.37 | -3.25 |
Brederode S.A. | BREB | Apr 16, 2025 | 107.42 | -1.74 |
Campine nv | CAMB | Apr 16, 2025 | 163.00 | +1.88 |
Candela Invest | CAND | Apr 16, 2025 | 1.68 | 0.00 |
Care Property Invest NV/SA | CPINV | Apr 16, 2025 | 12.14 | +1.85 |
Celyad Oncology SA | CYAD | Apr 16, 2025 | 0.58 | +21.85 |
Cenergy Holdings | CENER | Apr 16, 2025 | 8.60 | +1.18 |
Cofinimmo | COFB | Apr 16, 2025 | 63.65 | +4.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | Apr 16, 2025 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | Apr 16, 2025 | 41.78 | +0.72 |
Compagnie du Bois Sauvage S.A. | COMB | Apr 16, 2025 | 233.00 | +3.10 |
Compagnie d`Entreprises CFE SA | CFEB | Apr 16, 2025 | 7.36 | -1.34 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.